123 related articles for article (PubMed ID: 3974940)
1. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V
Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
Van den Brande P; Maurel A
Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
Racenberg J; Intaglietta M; Messmer K
Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
[TBL] [Abstract][Full Text] [Related]
4. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
Forconi S; Guerrini M; Agnusdei D; Di Perri T
Minerva Med; 1976 May; 67(25):1671-80. PubMed ID: 934519
[No Abstract] [Full Text] [Related]
5. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
Andreozzi GM; Lepore R
Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
[TBL] [Abstract][Full Text] [Related]
6. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
[TBL] [Abstract][Full Text] [Related]
7. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
Visconti W; Grillo N
Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842
[TBL] [Abstract][Full Text] [Related]
8. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
[TBL] [Abstract][Full Text] [Related]
9. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
Maurel A; Betrancourt JC; Van Frenkel R; Thuillez C
J Mal Vasc; 1995; 20(2):127-33. PubMed ID: 7650439
[TBL] [Abstract][Full Text] [Related]
10. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
Diehm C; Eckstein M; Hübsch-Müller C
Vasa; 1989; 18(1):40-7. PubMed ID: 2648691
[TBL] [Abstract][Full Text] [Related]
12. [Hemorrheology, microcirculation and oxygenation. Physiopathological and therapeutic aspects].
Ehrly M
Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):131-8. PubMed ID: 1767162
[TBL] [Abstract][Full Text] [Related]
13. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
14. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
Vigilance JE; Reid HL
J Diabetes Complications; 2008; 22(3):210-6. PubMed ID: 18413225
[TBL] [Abstract][Full Text] [Related]
15. Studies on haematocrit in peripheral arterial disease.
Lowe GD; Saniabadi A; Turner A; Lieberman P; Pollock J; Drury J
Klin Wochenschr; 1986 Oct; 64(19):969-74. PubMed ID: 3784449
[TBL] [Abstract][Full Text] [Related]
16. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies].
Mozzi E; Annoni F; Chiurazzi D; Rossi R; Pacini F; Martini A
Minerva Cardioangiol; 1984 Mar; 32(3):141-9. PubMed ID: 6374499
[No Abstract] [Full Text] [Related]
17. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
18. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
Forconi S; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Ralli L; Guerrini M; Di Perri T
J Int Med Res; 1984; 12(3):188-92. PubMed ID: 6734922
[No Abstract] [Full Text] [Related]
19. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
[TBL] [Abstract][Full Text] [Related]
20. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
